ORIGINAL CONTRIBUTION
    
PDF of Article    Article Full Text 

Home
Journal
Now in Medline / Index Medicus & ISI



Subscribe
Search
Discussion Forums
Join
Multimedia
Meeting Highlights
Lecture Presentations
Surgical Video Library
Private Lecture Series
Audio Interviews
Resources
Medline
Learning Center
Meetings
For Authors
Editorial Board
Sponsors
More Sponsors

Site News
Sign up for our newsletter:





Redo Mitral Surgery Using the Estech Endoclamp

(#2000-93990 ... June 8, 2000)

Guido Van Nooten, MD, PhD, Yves Van Belleghem, MD, Hans Van Overbeke, MD, Frank Caes, MD, Katrien François, MD, Michel De Pauw, MD, Frederick De Rijcke, MD, Jan Poelaert, MD, PhD

Heart Centre, University Hospital, Ghent, Belgium



ABSTRACT


Background: Redo-CABG surgery remains extremely hazardous in the presence of open bypass grafts. In our patients with mitral valve pathology with open and well-functioning bypass grafts, we explored alternative approaches in order to avoid damage to the grafts by extensive dissection and direct clamping of the ascending aorta. The "Estech procedure," which uses the Estech remote access perfusion (RAP) endoclamp catheter (Estech Inc., Danville, CA), was selected for these patients.

Methods: From January 1998 to January 2000, 10 patients underwent an Estech procedure for redo mitral surgery. All patients had previous cardiac operations such as coronary artery bypass grafting (CABG) and/or mitral valve procedures. The Estech procedure consisted of an anterior left thoracotomy and peripheral cannulation at femoral site using the Estech endovascular balloon technique. The series was comprised of seven mitral valve replacements, two valve reconstructions, and one closure of a paravalvular leak. One procedure had to be converted to a standard re-sternotomy due to extreme arteriosclerosis of the descending aorta with plaque dislocation at the time of catheter insertion. However, no damage was inflicted to the open bypass grafts.

Results: The follow-up period ranged from six to 30 months and was 100% complete. We encountered one hospital death in our group, which was due to a late post-operative intestinal infarction and multiple organ failure (MOF), and was not procedure related. As expected, morbidity was high in this compromised cohort, but no late death has occurred prior to submission of this article. All survivors progressed to an acceptable NYHA functional class.

Conclusion: The excellent results in this complex patient group inspired us to use the Estech procedure as a standard approach for redo mitral surgery.



AUTHOR/ARTICLE INFORMATION


Presented at the Third Annual Meeting of the International Society for Minimally Invasive Cardiac Surgery, Atlanta, GA, June 8-10, 2000.

Address correspondence and reprint requests to: Prof. Dr. Guido Van Nooten, Cardiac Surgery Department, University Hospital, De Pintelaan, 185, 9000 Ghent, Belgium, Phone: 32-9-2404700, Fax: 32-9-2403882, Email: GUIDO.VANNOOTEN@RUG.AC.BE

Keywords: Estech endovascular balloon technique, redo mitral valve surgery

 


ISSN#: 1522-6662
Copyright 2008 Forum Multimedia Publishing, LLC. All rights reserved.

The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Forum Multimedia Publishing, LLC, assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.